Dr. KK Sethi: Role Of Beta Blockers Indispensable In Acute MI
Beta blockers when administered early after the onset of acute MI showed 25% to 36% reduction in early and late mortality.
388 Total Views
Supported by an Unrestricted Educational Grant from
Dr. KK Sethi
Chairman, Managing Director & HOD - Cardiology
Delhi Heart and Lung Institute, New Delhi
Acute myocardial infarction is a consequence of blockage of the coronary arteries, a condition which beta blockers have proven to benefit, says Dr. KK Sethi in an interview with Dr. Rishi Jain.Beta blockers decrease the incidence of sudden cardiac death. They also decrease recurrence of ischemia and myocardial infarction, he adds.“In a country where not many heart patients have access to primary PCI, beta blockers have a big role to play in treatment of STEMI.”“The role of beta blockers as a antihypertensive drug is restricted to a certain category of patients. But there are much better drugs available in the Indian market for hypertension.”While Dr. Sethi discusses the benefits of beta blockers in a plethora of heart diseases other than acute MI, he also gives a warning against its side effect like bradycardia and low BP.“If a congestive heart failure worsens due to beta blockers, a revised dose with a little bit of diuretic may stabilize the condition.”“Despite the side effects, Beta blockers are very safe drugs, so long as you know how and when to use them properly. Apart from a few concerns in hypertension, beta blockers and their benefits are beyond question.”